Valuation

14 Feb 2020

It’s a tight race for autonomous driving patent leadership

New analysis gives unparalleled insight into the key players in self-drive technologies and shows Waymo, Toyota, GM and Ford vying for top spot

12 Feb 2020

Patent transfer sets stage for possible Ant Financial IPO

Assets assigned to the Alipay operator financed Alibaba’s purchase of a 33% stake in what could be one of the biggest Asian listings ever

Latest

View all
11 Feb 2020

Antitrust considerations now a much bigger factor in pharma patent dealmaking

Following recent forced divestments - and with growing political concern about life sciences acquisitions - the signs are that regulators will play a larger role in transactions Read more

7 Feb 2020

Johnson & Johnson takes the patent lead in medtech innovation

The company has surpassed other healthcare powerhouses and kept Apple and Alphabet at bay, but a robust portfolio does not guarantee smooth sailing Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

4 Feb 2020

Pharma companies need data strategies more than ever following recent CJEU decisions

Judgments from Europe’s top court rejecting a presumption of confidentiality for clinical study reports submitted for marketing authorisation have significant implications Read more

News

View all
1 Feb 2020

We need better thinking on US pharma patent reforms

As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate Read more

2 Jan 2020

Why the traditional US model of educating tomorrow’s lawyers must change

Intellectual property systems are becoming more complex and that makes law schools’ one-size-fits all approach looks increasingly out of date, says Franklin Pierce dean Read more

17 Dec 2019

Intel puts connected devices patent portfolio up for sale

After deal for cellular chip business with Apple, the company places rest of the assets that were on the market in the summer back on the auction block Read more

5 Dec 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value Read more

Analysis

View all
31 Jan 2020

It’s a tight race for quantum patent supremacy  

Portfolio analysis shows there is no clear leader right now, but Microsoft, IBM, Intel and Northrop Grumman are among those vying for top spot Read more

21 Jan 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade Read more

14 Jan 2020

Conversant case illustrates gauntlet facing SEP plaintiffs in China

The Chinese IP office knocked out several claims from the sole patent owned by the NPE that was deemed essential and infringed in a recent Nanjing FRAND ruling Read more

9 Jan 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases Read more

Insights

View all
1 Oct 2017

A round-up of IP-related quotes, observations and opinions from the recent past …

A round-up of IP-related quotes, observations and opinions from the recent past … Read more